You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

O6-methylguanine-DNA-methyltransferase (MGMT) methylated

Showing 26 - 50 of 4,438
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Metastatic Colorectal Cancer Trial in Milan (Capecitabine, Temozolomide, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Milan, Mi, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021

Brain Cancer Trial in Worldwide (Nivolumab, Temozolomide, Radiotherapy)

Completed
Has Results
  • Brain Cancer
  • Birmingham, Alabama
  • +124 more
Mar 16, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Glioblastoma Multiforme, Adult Trial (Integrated boost technique (SIB) guided by PET FDOPA)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Integrated boost technique (SIB) guided by PET FDOPA
  • (no location specified)
Dec 7, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022

Glioblastoma, Brain Tumor, Cannabis Trial in United Kingdom (Sativex, Temozolomide, Sativex-matched )

Not yet recruiting
  • Glioblastoma
  • +3 more
  • Belfast, United Kingdom
  • +14 more
Nov 29, 2022

Grade IV Astrocytoma, Glioblastoma Trial in France (Temozolomide, folinic acid at pharmacological dose is the escalated drug,

Terminated
  • Grade IV Astrocytoma
  • Glioblastoma
  • Angers, France
  • +3 more
May 20, 2021

Utility of Primary Glioblastoma Cell Lines

Recruiting
  • Tumor
  • Brain Tumor
    • Pozzilli, IS, Italy
      Neuromed IRCCS
    Apr 9, 2021

    Glioblastoma, Adult Trial in Germany (APG101, Alectinib, Idasanutlin)

    Recruiting
    • Glioblastoma, Adult
    • Berlin, Germany
    • +12 more
    May 20, 2022

    Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)

    Suspended
    • Gliosarcoma
    • MGMT-Unmethylated Glioblastoma
    • Ipilimumab
    • +6 more
    • Birmingham, Alabama
    • +285 more
    Aug 24, 2022

    Glioblastoma Multiforme Trial in Calgary, Edmonton (Biomarker based treatment (Temozolomide monotherapy or Radiotherapy

    Recruiting
    • Glioblastoma Multiforme
    • Biomarker based treatment (Temozolomide monotherapy or Radiotherapy monotherapy)
    • Chemo-Radiotherapy consisting of 40 Gy in 15 daily fractions with concurrent temozolomide.
    • Calgary, Alberta, Canada
    • +1 more
    Jun 24, 2022

    Glioblastoma Trial in Bergen, Oslo (Bortezomib and Temozolomide Phase IB, Bortezomib and Temozolomide Phase II)

    Recruiting
    • Glioblastoma
    • Bortezomib and Temozolomide Phase IB
    • Bortezomib and Temozolomide Phase II
    • Bergen, Norway
    • +1 more
    Aug 24, 2021

    Glioblastoma Multiforme Trial in Ulm (Surgery)

    Recruiting
    • Glioblastoma Multiforme
    • Surgery
    • Ulm, Germany
      Department of Neurosurgery
    Apr 30, 2021

    Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

    Completed
    Has Results
    • Glioblastoma
    • Gliosarcoma
    • 3-Dimensional Conformal Radiation Therapy
    • +10 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 4, 2022

    Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)

    Recruiting
    • Immunotherapy
    • +3 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 2, 2021

    Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

    Recruiting
    • Glioblastoma Multiforme
    • Baltimore, Maryland
      Johns Hopkins Medical Institution
    Dec 5, 2022

    Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

    Recruiting
    • Glioblastoma Multiforme of Brain
    • Multipeptide plus XS15
    • Tübingen, BW, Germany
      University Hospital Tübingen
    May 9, 2022

    Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma

    Active, not recruiting
    • Glioblastoma
      • Birmingham, Alabama
      • +18 more
      Mar 7, 2022

      Glioblastoma Multiforme, MGMT-Unmethylated Glioblastoma Trial in Roma, Milano, Padova (Chlorpromazine Pill)

      Recruiting
      • Glioblastoma Multiforme
      • MGMT-Unmethylated Glioblastoma
      • Chlorpromazine Pill
      • Roma, Lazio, Italy
      • +2 more
      Jan 9, 2020

      MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

      Active, not recruiting
      • Myelodysplastic Syndromes
      • Myeloproliferative Neoplasm
      • Azacitidine Subcutaneous Injection or Intravenous Infusion
      • +2 more
      • Miami, Florida
      • +4 more
      Jun 20, 2022

      Newly Diagnosed Glioblastoma Multiforme Trial (SI-053)

      Not yet recruiting
      • Newly Diagnosed Glioblastoma Multiforme
      • (no location specified)
      Apr 4, 2022

      Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

      Not yet recruiting
      • Glioblastoma Multiforme
      • Glioblastoma
      • IGV-001 Cell Immunotherapy
      • +3 more
      • Newark, Delaware
      • +22 more
      Jun 24, 2022